NO20052524L - Aminerte isofiavonoidderivater og anvendelse derav - Google Patents

Aminerte isofiavonoidderivater og anvendelse derav

Info

Publication number
NO20052524L
NO20052524L NO20052524A NO20052524A NO20052524L NO 20052524 L NO20052524 L NO 20052524L NO 20052524 A NO20052524 A NO 20052524A NO 20052524 A NO20052524 A NO 20052524A NO 20052524 L NO20052524 L NO 20052524L
Authority
NO
Norway
Prior art keywords
aminated
isofiavonoid
derivatives
isoflavonone
aminating
Prior art date
Application number
NO20052524A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052524D0 (no
Inventor
Andrew Heaton
Graham Edmund Kelly
Jane Faragalla
John Bremner
Original Assignee
Novogen Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd
Publication of NO20052524D0 publication Critical patent/NO20052524D0/no
Publication of NO20052524L publication Critical patent/NO20052524L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
NO20052524A 2002-11-01 2005-05-26 Aminerte isofiavonoidderivater og anvendelse derav NO20052524L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952453A AU2002952453A0 (en) 2002-11-01 2002-11-01 Aminated isoflavonoid derivatives and uses thereof
PCT/AU2003/001446 WO2004039793A1 (fr) 2002-11-01 2003-11-03 Derives d'isoflavonoides amines et leurs utilisations

Publications (2)

Publication Number Publication Date
NO20052524D0 NO20052524D0 (no) 2005-05-26
NO20052524L true NO20052524L (no) 2005-05-26

Family

ID=28795843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052524A NO20052524L (no) 2002-11-01 2005-05-26 Aminerte isofiavonoidderivater og anvendelse derav

Country Status (10)

Country Link
US (1) US7714151B2 (fr)
EP (1) EP1556368A4 (fr)
JP (1) JP2006513997A (fr)
CN (1) CN1708490A (fr)
AU (1) AU2002952453A0 (fr)
CA (1) CA2504653A1 (fr)
MX (1) MXPA05004526A (fr)
NO (1) NO20052524L (fr)
NZ (1) NZ539034A (fr)
WO (1) WO2004039793A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004230841A1 (en) * 2003-04-03 2004-10-28 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
FR2873118B1 (fr) * 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
JP2006146490A (ja) * 2004-11-18 2006-06-08 Ricoh Co Ltd 印刷制御装置及び印刷制御プログラム
US20060134243A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
DE102005011822A1 (de) * 2005-03-15 2006-09-21 Merck Patent Gmbh Phthalazinone
JP2008533177A (ja) * 2005-03-24 2008-08-21 ノボジェン リサーチ ピーティーワイ リミテッド 抗炎症治療法
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
JP2010535815A (ja) * 2007-08-08 2010-11-25 バイオノボ・インコーポレーテッド モクセイ科トウネズミモチのエストロゲン性抽出物およびその使用
WO2009033075A1 (fr) * 2007-09-07 2009-03-12 Bionovo. Inc. Extraits oestrogéniques de scuttelaria barbata d. don de la famille labiatae et leurs utilisations
AU2008296072A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof
WO2009033025A1 (fr) * 2007-09-07 2009-03-12 Bionovo, Inc. Extraits œstrogéniques d'asparagus conchinchinensis (lour.) merr de la famille des liliacées et leurs utilisations
US20090068299A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Pueraria lobata Willd. Ohwi of the Leguminosae Family AND USES THEREOF
CA2706313A1 (fr) 2007-11-19 2009-05-28 Bionovo, Inc. Procedes de detection et de traitement de cancers utilisant un extrait de scuttelaria barbata
JP2011503237A (ja) 2007-11-19 2011-01-27 バイオノボ・インコーポレーテッド Ｓｃｕｔｅｌｌａｒｉａｂａｒｂａｔａｄ．ｄｏｎの精製抽出物を作製するためのプロセス
AU2008326429A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
AU2008326431A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
TWI324514B (en) * 2008-02-26 2010-05-11 Univ Kaohsiung Medical Isoflavone derivatives and pharmaceutical compositions comprising the same
JP2011516583A (ja) * 2008-04-14 2011-05-26 バイオノボ・インコーポレーテッド エストロゲン受容体β介在疾患の治療のためのカリコシン及びその類似物質
AU2009244315A1 (en) * 2008-05-06 2009-11-12 Bionovo, Inc. Estrogenic extracts for use in treating vaginal and vulvar atrophy
WO2009149411A2 (fr) * 2008-06-05 2009-12-10 Bionovo, Inc. Procédé de quantification de multiples agents bioactifs provenant de compositions botaniques
JP2011522822A (ja) * 2008-06-06 2011-08-04 バイオノボ・インコーポレーテッド エストロゲン受容体β媒介性病状の治療のためのダイオウ（Ｒｈｅｕｍｐａｌｍａｔｕｍ）由来のアントラキノンおよび類似体
CA2734523A1 (fr) * 2008-09-03 2010-03-11 Bionovo, Inc. Procedes et compositions destines au traitement du cancer
US20100190733A1 (en) * 2009-01-26 2010-07-29 Primus Pharmaceuticals, Inc. Methods of Treating Muscular Dystrophies
EP2424555A4 (fr) * 2009-04-28 2013-02-20 Bionovo Inc Procédé de réduction d'accumulation de graisse et d'induction de perte de poids
CN101716135B (zh) * 2010-01-08 2012-11-14 山西医科大学 大豆异黄酮固体分散体栓剂及其制备方法
CN102453028B (zh) * 2010-10-22 2014-07-30 沈阳药科大学 抗真菌剂—2-[（2，3-二氢-4H-苯并[b]噻喃-4-亚基）亚肼基]-4-氧代四氢噻（噁）唑-5-乙酸衍生物
US10568900B1 (en) 2013-03-15 2020-02-25 Suzanne Janine Paxton-Pierson Androgen effectors
JP6744860B2 (ja) * 2014-09-10 2020-08-19 システム バイオロジー アーゲー イソフラバンおよびその中間体の合成
JP2019513826A (ja) * 2016-04-06 2019-05-30 ノクソファーム リミティド 放射線療法の改善
US11559510B2 (en) 2016-04-06 2023-01-24 Noxopharm Limited Isoflavonoid composition with improved pharmacokinetics
EP4125870A1 (fr) 2020-03-30 2023-02-08 Noxopharm Limited Méthodes de traitement d'une inflammation associée à une infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX18911A (es) * 1988-12-27 1993-10-01 Du Pont Artropodicidas de semicarbazonas substituidas.
RU2067092C1 (ru) 1988-12-27 1996-09-27 Е.И.Дюпон Де Немур Энд Компани Производные семикарбазонов, способ уничтожения артроподов, артроподицидная композиция
EP0508425A1 (fr) * 1991-04-12 1992-10-14 Schering Corporation Amides bicycliques inhibiteurs de l'acyl-coenzyme A, cholestérol acyltransférase
CN1093086A (zh) * 1993-04-03 1994-10-05 华西医科大学药物研究所 异黄酮脂环烃醚及其肟衍生物

Also Published As

Publication number Publication date
CA2504653A1 (fr) 2004-05-13
US20060100238A1 (en) 2006-05-11
AU2002952453A0 (en) 2002-11-21
NZ539034A (en) 2008-04-30
EP1556368A4 (fr) 2010-07-28
WO2004039793A1 (fr) 2004-05-13
US7714151B2 (en) 2010-05-11
MXPA05004526A (es) 2005-07-26
NO20052524D0 (no) 2005-05-26
JP2006513997A (ja) 2006-04-27
CN1708490A (zh) 2005-12-14
EP1556368A1 (fr) 2005-07-27

Similar Documents

Publication Publication Date Title
NO20052524L (no) Aminerte isofiavonoidderivater og anvendelse derav
NO20093060L (no) Spirosykliske sykloheksanderivater
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
NO20085373L (no) P38 inhibitorer, deres fremstilling og anvendelse
SE0200920D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
AU2003228770A1 (en) Substituted pyrazolopyrimidines
TW200613243A (en) Novel compounds
NO20054329L (no) Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
SE9904505D0 (sv) Novel compounds
NO20066055L (no) Pyridinderivater
ATE301653T1 (de) Pyrazolopyridine
NO20054787D0 (no) Indenderivater som farmasotiske midler
NO20063062L (no) Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse
NO20002787L (no) Nye forbindelser
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
NO20061981L (no) Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
NO20062878L (no) Isoflavonoidpromedikamenter, terapeutiske sammensetninger derav og terapeutiske fremgangsmater som innbefatter de samme
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
ATE300541T1 (de) Pyrazolopyridinderivate
NO20092690L (no) Aminderivater og deres anvendelse i beta-2-adrenoreseptormedierte sykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application